Literature DB >> 8399908

A primate model of Ureaplasma urealyticum infection in the premature infant with hyaline membrane disease.

W F Walsh1, J Butler, J Coalson, D Hensley, G H Cassell, R A deLemos.   

Abstract

Cultures positive for Ureaplasma urealyticum in babies weighing < 1000 g have been associated with both chronic lung disease (CLD) and death, but no definite causality has been established. To further investigate the role of the organism in CLD, we colonized premature baboons with U. urealyticum and compared resulting pathology with that in uninoculated control animals. Using an established model of prematurity, the 140-day-gestation baboon, three animals were colonized with U. urealyticum via endotracheal tube. All had hyaline membrane disease, indistinguishable from disease in human infants, and U. urealyticum infection. Samples obtained from nasopharynx, trachea, pleural fluid, and, at necropsy, lung tissue produced positive cultures. Culture of blood from one animal yielded U. urealyticum. On pathologic examination, after 6 days of ventilation, all three of the infected animals had the specific pathologic finding of bronchiolitis with epithelial ulceration not seen in four uninfected control animals. Thus, U. urealyticum is capable of causing a pathologically recognizable pulmonary lesion in premature primates with hyaline membrane disease.

Entities:  

Mesh:

Year:  1993        PMID: 8399908     DOI: 10.1093/clinids/17.supplement_1.s158

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia.

Authors:  Hazem E Hassan; Ahmed A Othman; Natalie D Eddington; Lynn Duffy; Li Xiao; Ken B Waites; David A Kaufman; Karen D Fairchild; Michael L Terrin; Rose M Viscardi
Journal:  J Clin Pharmacol       Date:  2010-11-23       Impact factor: 3.126

Review 2.  Perinatal inflammation and lung injury.

Authors:  Rose Marie Viscardi
Journal:  Semin Fetal Neonatal Med       Date:  2011-09-08       Impact factor: 3.926

3.  Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by Ureaplasma urealyticum in macrophages.

Authors:  Y H Li; Z Q Yan; J S Jensen; K Tullus; A Brauner
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Pulmonary vascular and alveolar development in preterm lambs chronically colonized with Ureaplasma parvum.

Authors:  Graeme R Polglase; Richard G B Dalton; Ilias Nitsos; Christine L Knox; J Jane Pillow; Alan H Jobe; Timothy J M Moss; John P Newnham; Suhas G Kallapur
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-05-21       Impact factor: 5.464

5.  Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults.

Authors:  W M Manimtim; J D Hasday; L Hester; K D Fairchild; J C Lovchik; R M Viscardi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 6.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

7.  Characterization of a murine model of Ureaplasma urealyticum pneumonia.

Authors:  Rose M Viscardi; Jennifer Kaplan; Judith C Lovchik; Ju Ren He; Lisa Hester; Srinivas Rao; Jeffrey D Hasday
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

9.  Surfactant protein-A limits Ureaplasma-mediated lung inflammation in a murine pneumonia model.

Authors:  Mobolaji E Famuyide; Jeffrey D Hasday; Heather C Carter; Kirsty L Chesko; Ju-Ren He; Rose M Viscardi
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

Review 10.  Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence.

Authors:  Rose Marie Viscardi; Jeffrey D Hasday
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.